Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Liu, Jingmei ^a   Lu, Huimei ^a   Ohgaki, Hiroko ^b   Merlo, Adrian ^c   Shen, Zhiyuan ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BRCA2 AND CDKN1A INTERACTING PROTEIN; BRCA2 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; GENOMIC DNA; GLIAL FIBRILLARY ACIDIC PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; BCCIP PROTEIN, HUMAN; CALCIUM BINDING PROTEIN; CELL CYCLE PROTEIN; NUCLEAR PROTEIN;

ARTICLE; CANCER GRADING; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; ASTROCYTOMA; GENE DOSAGE; GENETICS; METABOLISM; PATHOLOGY; PROTEIN BINDING;

ASTROCYTOMA; BRCA2 PROTEIN; CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; GENE DOSAGE; HUMANS; NUCLEAR PROTEINS; PROTEIN BINDING;

EID: 70049086787     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-268     Document Type: Article

References (55)

1. Rasheed BK Fuller GN Friedman AH Bigner DD Bigner SH Loss of heterozygosity for 10q loci in human gliomas Genes Chromosomes Cancer 1992, 5:75-82 10.1002/gcc.2870050111 1384665
2. Karlbom AE James CD Boethius J Cavenee WK Collins VP Nordenskjold M Larsson C Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10 Hum Genet 1993, 92:169-74 10.1007/BF00219686 8370584
3. Balesaria S Brock C Bower M Clark J Nicholson SK Lewis P de Sanctis S Evans H Peterson D Mendoza N et al Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas Br J Cancer 1999, 81:1371-7 10.1038/sj.bjc.6693403 10604735
4. Steck PA Lin H Langford LA Jasser SA Koul D Yung WK Pershouse MA Functional and molecular analyses of 10q deletions in human gliomas Genes Chromosomes Cancer 1999, 24:135-43 10.1002/ (SICI)1098-2264(199902)24:2<135::AID-GCC6>3.0.CO;2-A 9885980
5. Fujisawa H Reis RM Nakamura M Colella S Yonekawa Y Kleihues P Ohgaki H Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas Lab Invest 2000, 80:65-72 10.1038/ labinvest.3780009 10653004
6. Daido S Takao S Tamiya T Ono Y Terada K Ito S Ouchida M Date I Ohmoto T Shimizu K Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions Oncol Rep 2004, 12:789-95 15375501
7. Hill C Hunter SB Brat DJ Genetic markers in glioblastoma: Prognostic significance and future therapeutic implications Adv Anat Pathol 2003, 10:212-7 10.1097/00125480-200307000-00004 12826827
8. Ohgaki H Genetic pathways to glioblastomas Neuropathology 2005, 25:1-7 10.1111/j.1440-1789.2004.00600.x 15822813
9. Ohgaki H Dessen P Jourde B Horstmann S Nishikawa T Di Patre PL Burkhard C Schuler D Probst-Hensch NM Maiorka PC et al Genetic pathways to glioblastoma: A population-based study Cancer Res 2004, 64:6892-9 10.1158/0008-5472.CAN-04-1337 15466178
10. Merlo A Genes and pathways driving glioblastomas in humans and murine disease models Neurosurg Rev 2003, 26:145-58 12783270
11. Maier D Zhang Z Taylor E Hamou MF Gratzl O Van Meir EG Scott RJ Merlo A Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/ MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas Oncogene 1998, 16:3331-5 10.1038/sj.onc.1201832 9681833
12. Ohgaki H Kleihues P Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas J Neuropathol Exp Neurol 2005, 64:479-89 15977639
13. Homma T Fukushima T Vaccarella S Yonekawa Y Di Patre PL Franceschi S Ohgaki H Correlation among pathology, genotype, and patient outcomes in glioblastoma J Neuropathol Exp Neurol 2006, 65:846-54 10.1097/ 01.jnen.0000235118.75182.94 16957578
14. Ittmann M Allelic loss on chromosome 10 in prostate adenocarcinoma Cancer Res 1996, 56:2143-7 8616863
15. Ittmann MM Chromosome 10 alterations in prostate adenocarcinoma (review) Oncol Rep 1998, 5:1329-35 9769364
16. Peiffer SL Herzog TJ Tribune DJ Mutch DG Gersell DJ Goodfellow PJ Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers Cancer Res 1995, 55:1922-6 7728760
17. Petersen S Wolf G Bockmuhl U Gellert K Dietel M Petersen I Allelic loss on chromosome 10q in human lung cancer: Association with tumour progression and metastatic phenotype Br J Cancer 1998, 77:270-6 9460998
18. Couzin J The twists and turns in BRCA's path Science 2003, 302:591-3 10.1126/science.302.5645.591 14576418
19. Meng X Lu H Shen Z BCCIP functions through p53 to regulate the expression of p21Waf1/Cip1 Cell Cycle 2004, 3:1457-62 15539944
20. Liu J Yuan Y Huan J Shen Z Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2 Oncogene 2001, 20:336-45 10.1038/sj.onc.1204098 11313963
21. Ono T Kitaura H Ugai H Murata T Yokoyama KK Iguchi-Ariga SM Ariga H TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase J Biol Chem 2000, 275:31145-54 10.1074/jbc.M003031200 10878006
22. Lu H Guo X Meng X Liu J Allen C Wray J Nickoloff JA Shen Z The BRCA2-interacting protein BCCIP functions in RAD51 and BRCA2 focus formation and homologous recombinational repair Mol Cell Biol 2005, 25:1949-57 10.1128/MCB.25.5.1949-1957.2005 549367 15713648
23. Meng X Liu J Shen Z Inhibition of G1 to S cell cycle progression by BCCIP beta Cell Cycle 2004, 3:343-8 14726710
24. Lu H Yue J Meng X Nickoloff JA Shen Z BCCIP regulates homologous recombination by distinct domains and suppresses spontaneous DNA damage Nucleic Acids Res 2007, 35:7160-7170 10.1093/nar/gkm732 2175368 17947333
25. Wray J Liu J Nickoloff JA Shen Z Distinct RAD51 associations with RAD52 and BCCIP in response to DNA damage and replication stress Cancer Research 2008, 68:2699-2707 10.1158/0008-5472.CAN-07-6505 18413737
26. Meng X Yue J Liu Z Shen Z Abrogation of the transactivation activity of p53 by BCCIP down-regulation J Biol Chem 2007, 282:1570-6 10.1074/ jbc.M607520200 2679999 17135243
27. Meng X Fan J Shen Z Roles of BCCIP in chromosome stability and cytokinesis Oncogene 2007, 26:6253-60 10.1038/sj.onc.1210460 2667889 17452982
28. Roversi G Pfundt R Moroni RF Magnani I van Reijmersdal S Pollo B Straatman H Larizza L Schoenmakers EF Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines Oncogene 2006, 25:1571-83 10.1038/ sj.onc.1209177 16247447
29. Reifenberger G Collins VP Pathology and molecular genetics of astrocytic gliomas J Mol Med 2004, 82:656-70 10.1007/s00109-004-0564-x 15316624
30. Kleihues P Louis DN Scheithauer BW Rorke LB Reifenberger G Burger PC Cavenee WK The WHO classification of tumors of the nervous system J Neuropathol Exp Neurol 2002, 61:215-25 discussion 226-9. 11895036
31. Maier D Comparone D Taylor E Zhang Z Gratzl O Van Meir EG Scott RJ Merlo A New deletion in low-grade oligodendroglioma at the glioblastoma suppressor locus on chromosome 10q25-26 Oncogene 1997, 15:997-1000 10.1038/sj.onc.1201209 9285695
32. Watanabe T Nakamura M Yonekawa Y Kleihues P Ohgaki H Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogliomas Acta Neuropathol 2001, 101:185-9 11307615
33. Meng X Liu J Shen Z Genomic structure of the human BCCIP gene and its expression in cancer Gene 2003, 302:139-46 10.1016/S0378-1119(02)01098-3 12527204
34. Shih AH Holland EC Developmental neurobiology and the origin of brain tumors J Neurooncol 2004, 70:125-36 10.1007/s11060-004-2746-3 15674474
35. Eng LF Ghirnikar RS GFAP and astrogliosis Brain Pathol 1994, 4:229-37 10.1111/j.1750-3639.1994.tb00838.x 7952264
36. Fujisawa H Kurrer M Reis RM Yonekawa Y Kleihues P Ohgaki H Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter Am J Pathol 1999, 155:387-94 1866845 10433932
37. Lee JO Yang H Georgescu MM Di Cristofano A Maehama T Shi Y Dixon JE Pandolfi P Pavletich NP Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association Cell 1999, 99:323-34 10.1016/S0092-8674(00)81663-3 10555148
38. Rossi DJ Weissman IL Pten, tumorigenesis, and stem cell self-renewal Cell 2006, 125:229-31 10.1016/j.cell.2006.04.006 16630811
39. Chow LM Baker SJ PTEN function in normal and neoplastic growth Cancer Lett 2006, 241:184-96 10.1016/j.canlet.2005.11.042 16412571
40. Stiles B Groszer M Wang S Jiao J Wu H PTENless means more Dev Biol 2004, 273:175-84 10.1016/j.ydbio.2004.06.008 15328005
41. Leslie NR Downes CP PTEN function: How normal cells control it and tumour cells lose it Biochem J 2004, 382:1-11 10.1042/BJ20040825 1133909 15193142
42. Scott DK Straughton D Cole M Bailey S Ellison DW Clifford SC Identification and analysis of tumor suppressor loci at chromosome 10q23.3-10q25.3 in medulloblastoma Cell Cycle 2006, 5:2381-9 17102621
43. Ariyanayagam-Baksh SM Baksh FK Swalsky PA Finkelstein SD Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma Mod Pathol 2003, 16:992-5 10.1097/01.MP.0000087421.44975.1C 14559981
44. Herbst RA Podewski EK Mommert S Kapp A Weiss J PTEN and MXI1 allelic loss on chromosome 10q is rare in melanoma in vivo Arch Dermatol Res 1999, 291:567-9 10.1007/s004030050456 10552217
45. Prochownik EV Eagle Grove L Deubler D Zhu XL Stephenson RA Rohr LR Yin X Brothman AR Commonly occurring loss and mutation of the MXI1 gene in prostate cancer Genes Chromosomes Cancer 1998, 22:295-304 10.1002/ (SICI)1098-2264(199808)22:4<295::AID-GCC5>3.0.CO;2-Q 9669667
46. Kuczyk MA Serth J Bokemeyer C Schwede J Herrmann R Machtens S Grunewald V Hofner K Jonas U The MXI1 tumor suppressor gene is not mutated in primary prostate cancer Oncol Rep 1998, 5:213-6 9458379
47. Wechsler DS Shelly CA Petroff CA Dang CV MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells Cancer Res 1997, 57:4905-12 9354456
48. Kim SK Ro JY Kemp BL Lee JS Kwon TJ Hong WK Mao L Identification of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer Oncogene 1998, 17:1749-53 10.1038/sj.onc.1202073 9796705
49. Wang DS Rieger-Christ K Latini JM Moinzadeh A Stoffel J Pezza JA Saini K Libertino JA Summerhayes IC Molecular analysis of PTEN and MXI1 in primary bladder carcinoma Int J Cancer 2000, 88:620-5 10.1002/ 1097-0215(20001115)88:4<620::AID-IJC16>3.0.CO;2-Z 11058880
50. Delnatte C Sanlaville D Mougenot JF Vermeesch JR Houdayer C Blois MC Genevieve D Goulet O Fryns JP Jaubert F et al MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells Am J Hum Genet 2006, 78:1066-74 10.1086/504301 1474102 16685657
51. Mollenhauer J Wiemann S Scheurlen W Korn B Hayashi Y Wilgenbus KK von Deimling A Poustka A DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours Nat Genet 1997, 17:32-9 10.1038/ng0997-32 9288095
52. Sasaki H Betensky RA Cairncross JG Louis DN DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis Cancer Res 2002, 62:1790-6 11912156
53. Sanson M Leuraud P Aguirre-Cruz L He J Marie Y Cartalat-Carel S Mokhtari K Duffau H Delattre JY Hoang-Xuan K Analysis of loss of chromosome 10q, DMBT1 homozygous deletions, and PTEN mutations in oligodendrogliomas J Neurosurg 2002, 97:1397-401 10.3171/jns.2002.97.6.1397 12507139
54. Pang JC Dong Z Zhang R Liu Y Zhou LF Chan BW Poon WS Ng HK Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors Int J Cancer 2003, 105:76-81 10.1002/ijc.11019 12672033
55. Rewari A Lu H Parikh R Yang Q Shen Z Haffty BG BCCIP as a prognostic marker for radiotherapy of laryngeal cancer Radiother Oncol 2009, 90:183-8 10.1016/j.radonc.2008.10.020 19046788